NEW YORK, NY--(Marketwired - April 27, 2017) - Artemis Therapeutics, Inc. (OTC PINK: ATMS), ("Artemis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of ...
Immunologic Response and Pathogenic Mechanisms of Cytomegalovirus Infection in Transplant Recipients
Immunity mechanisms of cytomegalovirus infection control have been studied recently and have contributed to the better understanding of the pathogenesis of this disease in patients with a solid organ ...
Cytomegalovirus (CMV) infection remains a common complication after allogeneic hematopoietic-cell transplantation. Letermovir is an antiviral drug that inhibits the CMV–terminase complex. In this ...
Cytomegalovirus (CMV) belongs to the herpes virus family. Infection with CMV is very common. Between 50% and 80% of people in the United States have had a CMV infection by the time they are 40 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results